Zobrazeno 1 - 10
of 517
pro vyhledávání: '"Brad S Kahl"'
Autor:
Paolo F Caimi, Weiyun Z Ai, Juan Pablo Alderuccio, Kirit M Ardeshna, Mehdi Hamadani, Brian Hess, Brad S Kahl, John Radford, Melhem Solh, Anastasios Stathis, Pier Luigi Zinzani, Ying Wang, Yajuan Qin, Luqiang Wang, Cindy Xu, Carmelo Carlo-Stella
Publikováno v:
HemaSphere, Vol 7, p e402511c (2023)
Externí odkaz:
https://doaj.org/article/979bb44e11154e29b5cffd1614fbdd2a
Autor:
Martin Dreyling, Andre Goy, Georg Hess, Brad S. Kahl, José-Ángel Hernández-Rivas, Natasha Schuier, Keqin Qi, Sanjay Deshpande, Angeline Zhu, Lori Parisi, Michael L. Wang
Publikováno v:
HemaSphere, Vol 6, Iss 5, p e712 (2022)
Externí odkaz:
https://doaj.org/article/89d6d5174cfe41b2b75b096c51736769
Autor:
Narendranath, Epperla, Jeffrey M, Switchenko, Veronika, Bachanova, James N, Gerson, Stefan K, Barta, Max J, Gordon, Alexey V, Danilov, Natalie Sophia, Grover, Stephanie P, Mathews, Madelyn, Burkart, Reem, Karmali, Yazeed, Sawalha, Brian T, Hill, Nilanjan, Ghosh, Steven I, Park, David A, Bond, Mehdi, Hamadani, Timothy S, Fenske, Peter, Martin, Jin, Guo, Mary-Kate, Malecek, Brad S, Kahl, Christopher R, Flowers, Brian K, Link, Lawrence D, Kaplan, David J, Inwards, Andrew, Feldman, Eric D, Hsi, Kami, Maddocks, Kristie, Blum, Namcy L, Bartlett, James R, Cerhan, John P, Leonard, Thomas M, Habermann, Matthew J, Maurer, Jonathon B, Cohen
Publikováno v:
Blood Advances. 7:2287-2296
The prognostic relevance of diagnosis to treatment interval (DTI) in patients with newly diagnosed mantle cell lymphoma (MCL) is unknown. Hence, we sought to evaluate the impact of DTI on outcomes in MCL using 3 large datasets (1) the University of I
Autor:
Juan Pablo Alderuccio, Isildinha M. Reis, Jean L. Koff, Melissa C. Larson, Dai Chihara, Wei Zhao, Sara Haddadi, Thomas M. Habermann, Peter Martin, Jennifer R. Chapman, Christopher Strouse, Brad S. Kahl, Jonathon B. Cohen, Jonathan W. Friedberg, James R. Cerhan, Christopher R. Flowers, Izidore S. Lossos
Publikováno v:
Blood. 141:1888-1893
Autor:
Prashasti Agrawal, Kevin A. David, Zhengming Chen, Suchitra Sundaram, Seo-Hyun Kim, Ryan Vaca, Yong Lin, Samuel Singer, Mary-Kate Malecek, Jordan Carter, Adam Zayac, Myung Sun Kim, Nishitha Reddy, Douglas Ney, Alma Habib, Christopher Strouse, Jerome Graber, Veronika Bachanova, Sidra Salman, Jean A. Vendiola, Nasheed Hossain, Mazie Tsang, Ajay Major, Maher K. Gandhi, Colm Keane, David A. Bond, Matthew Folstad, Julie Chang, Angel Mier-Hicks, Pallawi Torka, Priya Rajakumar, Parameswaran Venugopal, Stephanie Berg, Michael Glantz, Samuel A. Goldlust, Rahul Matnani, Pallavi Kumar, Thomas A. Ollila, Johnny Cai, Stephen E. Spurgeon, Alex G. Sieg, Joseph Cleveland, Narendranath Epperla, Reem Karmali, Seema Naik, Sonali M. Smith, James L. Rubenstein, Brad S. Kahl, Amy Chadburn, Andrew M. Evens, Peter Martin
Publikováno v:
Leukemia & Lymphoma. :1-9
Autor:
Pallawi Torka, Levi D. Pederson, Michael V. Knopp, David Poon, Jun Zhang, Brad S. Kahl, Howard R. Higley, Gary Kelloff, Jonathan W. Friedberg, Lawrence H. Schwartz, Wyndham H. Wilson, John P. Leonard, Nancy L. Bartlett, Heiko Schöder, Amy S. Ruppert
Publikováno v:
Cancer Medicine. 12:8211-8217
Autor:
Brian T. Hess, Anshu Giri, Yeonhee Park, Krina K. Patel, Brian K. Link, Grzegorz S. Nowakowski, Seth M. Maliske, Sonia Fortin, Julio C. Chavez, Hayder Saeed, Brian T. Hill, Alex V. Mejia Garcia, Kami J. Maddocks, Walter Hanel, Nina D. Wagner‐Johnston, Marcus R. Messmer, Brad S. Kahl, Marcus Watkins, Juan Pablo Alderuccio, Izidore S. Lossos, Sunita Nathan, Victor M. Orellana‐Noia, Craig A. Portell, Daniel J. Landsburg, Emily C. Ayers, Jorge J. Castillo
Publikováno v:
American Journal of Hematology. 98:300-308
Plasmablastic lymphoma (PBL) is a rare entity, commonly associated with immunosuppressed states such as human immunodeficiency virus (HIV) infection or solid organ transplant. The clinical course is characterized by high relapse rates and a poor prog
Autor:
Matthew J. Cortese, Wei Wei, Sebastian Cerdeña, Marcus P. Watkins, Marissa Olson, Gray Jodon, Jeff Kaiser, Bradley Haverkos, Mitchell E. Hughes, Esin Namoglu, Natalie S. Grover, Anson Snow, Victor Orellana-Noia, Magdalena Rainey, Mohammad Sohail, Joslyn Rudoni, Craig Portell, Timothy Voorhees, Daniel J. Landsburg, Manali Kamdar, Brad S. Kahl, Brian T. Hill
Publikováno v:
Leukemia & Lymphoma. 64:107-118
Patients with double- and triple-hit lymphomas (DHL/THL) have inferior outcomes with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP), and higher-intensity regimens such as dose-adjusted (DA)-EPOCH-R are standard. Dose-i
Autor:
Juan P. Alderuccio, Weiyun Z. Ai, John Radford, Melhem Solh, Kirit M. Ardeshna, Matthew A. Lunning, Brian T. Hess, Pier L. Zinzani, Anastasios Stathis, Carmelo Carlo-Stella, Mehdi Hamadani, Brad S. Kahl, David Ungar, Turk Kilavuz, Eric Yu, Yajuan Qin, Paolo F. Caimi
Publikováno v:
Alderuccio, J P, Ai, W Z, Radford, J, Solh, M M, Ardeshna, K M, Lunning, M, Hess, B, Luigi Zinzani, P, Stathis, A, Carlo Stella, C, Hamadani, M, Kahl, B S, Ungar, D, Kilavuz, T, Yu, E, Qin, Y G & Caimi, P F 2022, ' Loncastuximab tesirine in relapsed/refractory high-grade B-cell lymphoma : a subgroup analysis from the LOTIS-2 study ', Blood Advances, vol. 6, no. 16, pp. 4736-4739 . https://doi.org/10.1182/bloodadvances.2022007782
Autor:
Richard L. Wahl, Eric C. Frey, Heather A. Jacene, Brad S. Kahl, Steven Piantadosi, Jesus A. Bianco, Richard J. Hammes, Miah Jung, Wayne Kasecamp, Bin He, George Sgouros, Ian W. Flinn, Lode J. Swinnen
Publikováno v:
Cancers, Vol 13, Iss 11, p 2828 (2021)
Purpose: We prospectively evaluated the feasibility of SPECT-CT/planar organ dosimetry-based radiation dose escalation radioimmunotherapy in patients with recurrent non-Hodgkin’s lymphoma using the theranostic pair of 111In and 90Y anti-CD20 ibritu
Externí odkaz:
https://doaj.org/article/0fb82817dab849cfbec63e1445ce28a5